Patent intelligence · US
US 9008184
Multiple sign bit hiding within a transform unit
Multiple sign bit hiding within a transform unit
Patent details — US 9008184
- Jurisdiction
- US
- Status
- granted
- Grant date
- Apr 14, 2015
- Expiration
- Apr 9, 2035
- Applicant
- BlackBerry Limited
- Claims
- 26
- CPC classes
- A61K, A61K31/12, A61K31/7048, A61K36/185
Quick answer
US 9008184 (Multiple sign bit hiding within a transform unit) is held by BlackBerry Limited. Status: granted. Granted Apr 14, 2015. Expires Apr 9, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BlackBerry Limited
- Grant date
- Expiration
- Claims
- 26
- CPC classes
- A61K, A61K31/12, A61K31/7048, A61K36/185, A61K36/28, A61K36/324
More from BlackBerry Limited
Related pharmaceutical patents in our USPTO index.
-
US 12343394
CD38 modulating antibody agents
granted -
US 12325699
Antibacterial compounds
granted -
US 12304964
CD38 modulating antibody
granted -
US 12187754
LpxC inhibitors and uses thereof
granted -
US 12161717
CD38 modulating antibody agents
granted -
US 12162949
CD38 antibody
granted -
US 11897873
Kappa opioid receptor antagonists and products and methods related thereto
granted -
US 11780930
CD38 modulating antibody
granted
Frequently asked questions
What is US patent 9008184?
US 9008184 (Multiple sign bit hiding within a transform unit) is held by BlackBerry Limited. Status: granted. Granted Apr 14, 2015. Expires Apr 9, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9008184?
BlackBerry Limited is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 38 pharmaceutical patents for this assignee.
When does US 9008184 expire?
Our index shows an expiration date of Apr 9, 2035 (9 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.